Related Experiment Video
Updated: Jul 13, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases
A Aigelsreiter1, E Janig, C Stumptner
1Institute of Pathology, Medical University of Graz, Graz, Austria.
Abstract:
Defective protein folding is responsible for many diseases. Although these diseases seem to be quite diverse at the first glance, there is evidence for common pathogenetic principles. The basis of the pathological changes is the cell's inability to prevent protein misfolding, to revert misfolded proteins to normal or to eliminate misfolded proteins by degradation. This could result in deposition of potentially cytotoxic protein aggregates (protein aggregation diseases). Chronic degenerative diseases of the central nervous system (e.g. Alzheimer's and Parkinson's disease), the amyloidoses, but also chronic liver diseases, for example alcoholic and nonalcoholic steatohepatitis, belong to this category of disorders. This review highlights general pathogenic principles of protein aggregation diseases based on immunohistochemical and biochemical studies as well as observations in a mouse model for protein aggregation in the context of alcoholic and nonalcoholic steatohepatitis. The cellular defense mechanisms involved in protein quality control as well as the pathogenesis of protein aggregation diseases will be discussed.
Insights
Defective protein folding causes diseases like Alzheimer's and liver conditions. This review explores common pathogenic principles and cellular defense mechanisms in protein aggregation diseases.
Area of Science:
- Molecular Biology
- Pathology
- Cell Biology
Background:
- Defective protein folding underlies diverse diseases, including neurodegenerative and chronic liver conditions.
- Common pathogenetic principles link these disorders, stemming from cellular inability to manage misfolded proteins.
- Protein aggregation diseases arise from cellular failures in preventing misfolding, refolding, or degrading aberrant proteins.
Purpose of the Study:
- To highlight general pathogenic principles of protein aggregation diseases.
- To discuss cellular defense mechanisms in protein quality control.
- To examine pathogenesis in the context of alcoholic and nonalcoholic steatohepatitis.
Main Methods:
- Immunohistochemical studies
- Biochemical studies
- Observations in a mouse model for protein aggregation
Main Results:
- Evidence for common pathogenetic principles in diverse protein misfolding diseases.
- Identification of cellular defense mechanisms crucial for protein quality control.
- Insights into the pathogenesis of protein aggregation diseases, including steatohepatitis.
Conclusions:
- Cellular dysfunction in protein quality control is a central mechanism in protein aggregation diseases.
- Understanding these principles aids in comprehending diseases like Alzheimer's, Parkinson's, and various liver conditions.
- Further research into cellular defense and pathogenesis can inform therapeutic strategies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...

